39 studies found for:    " June 26, 2013":" July 26, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
21 Completed Sustainable HIV Risk Reduction Strategies for CJ Systems
Condition: HIV Risk Behaviors
Intervention: Behavioral: WaySafe
22 Recruiting Integrating ENGagement and Adherence Goals Upon Entry iENGAGE to Control HIV
Condition: HIV
Intervention: Behavioral: Based on behavioral motivational interviewing (MI) technique
23 Completed Juvenile Detention to Community Life
Conditions: Substance Use;   Delinquency;   Risk for HIV Infection
Interventions: Behavioral: Multidimensional Family Therapy Cross-Systems;   Behavioral: Enhanced Services as Usual
24 Recruiting A Prospective, Observational Study of Individuals Who Seroconvert While Taking Truvada® for Pre-Exposure Prophylaxis (PrEP)
Condition: HIV
Intervention:
25 Recruiting Seroconversions, Resistance, Adverse Events and Drug Adherence Among Subjects Taking Truvada® for PrEP: A Case Control Study
Condition: HIV
Intervention:
26 Recruiting The Interaction of Two HIV Medications With Blood Clot Medications in Healthy Volunteers
Condition: HIV
Interventions: Drug: Ritonavir;   Drug: Cobicistat
27 Recruiting Preventing Bacterial and Viral Infections Among Injection Drug Users
Conditions: Bacterial Infection;   HIV
Intervention: Behavioral: SKIN Intervention
28 Active, not recruiting The Impact of Helicobacter Pylori Infection on Immune Regulation and Clinical Course in HIV Patients in Ghana
Conditions: HIV;   Bacterial Infection Due to Helicobacter Pylori (H. Pylori)
Intervention:
29 Recruiting Population Effects of Antiretroviral Therapy to Reduce HIV Transmission (PopART)
Condition: HIV
Interventions: Other: Universal Testing with immediate ART;   Other: Universal Testing with ART eligibility according to National Guidelines;   Other: Standard of Care
30 Recruiting Oligonucleotide Ligation Assay (OLA) Resistance Study
Condition: HIV Positive
Intervention: Other: Pre-ART Oligonucleotide Assay (OLA)
31 Not yet recruiting CHANGES IN LIVER STEATOSIS AFTER SWITCHING TO RALTEGRAVIR IN HIV/HCV COINFECTION
Conditions: HCV Coinfection;   HIV Infection
Interventions: Drug: Raltegravir;   Drug: Efavirenz
32 Withdrawn Evaluating the Safety and Immune Response of DNA/MVA Vaccines in HIV-1-Infected Young Adults Taking Anti-HIV Medications
Condition: HIV Infections
Interventions: Biological: GEO-D03 DNA Vaccine;   Biological: MVA/HIV62B Vaccine;   Biological: Placebo for DNA GEO-D03;   Biological: Placebo for MVA/HIV62B Vaccine
33 Completed An Observational Study of Induction Therapy With Fuzeon (Enfuvirtide) in Combination With Antiretroviral Drugs in Patients With HIV-1 Infection
Condition: HIV Infections
Intervention:
34 Completed Evaluation of the Impact of Mobile Phone Messages on ART and PMTCT Adherence in Mozambique
Condition: HIV-positive
Intervention: Behavioral: SMS reminders
35 Recruiting Epicardial Adipose Tissue And Coronary Risk In HIV-Infected Patients
Condition: Hiv Infection
Intervention: Biological: blood sampling,
36 Recruiting Evaluating Pharmacokinetic Interactions With Vaginal Ring Contraceptives and ART
Condition: HIV-1 Infection
Interventions: Device: Etonogestrel/ethinyl estradiol vaginal ring (NuvaRing);   Drug: Efavirenz;   Drug: Atazanavir/Ritonavir
37 Not yet recruiting Using Mobile Health to Respond Early to Acute Exacerbations of COPD in HIV
Conditions: COPD;   COPD Exacerbation
Intervention: Other: mHealth Intervention
38 Recruiting Comparing Treatments for HIV-Infected Opioid and Alcohol Users in an Integrated Care Effectiveness Study
Conditions: Opioid Use Disorder;   Alcohol Use Disorder
Interventions: Drug: Extended Release Naltrexone;   Other: Treatment As usual
39 Recruiting Youth Drug Abuse Prevention in Kazakhstan
Condition: Drug Use
Interventions: Behavioral: Kazakhstani Family Together;   Behavioral: Usual Care Alone

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-39) Next Page   
Indicates status has not been verified in more than two years